Abstract

The protection of critical infrastructure (water, energy, food supply, healthcare etc.) from cyberattack has…

The unproven stem cell intervention industry is a worldwide, direct-to-consumer market where clinics offer stem cells or stem cell-derived components to patients with little to no scientific or clinical basis. In this paper, the authors call for the establishment of a World Health Organization Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. Stem Cell Reports: https://doi.org/10.1016/j.stemcr.2021.05.004

Existing innovation in outcomes measurement and resource management, coupled with the competitive pressures of Covid-19, create a unique window for value creation within surgical care, the authors write. Read their article in the Annals of Surgery.

This study presents an integrated framework for hurricane risk assessment of petroleum infrastructure under changing climatic conditions, calculating risk in terms of monetary loss.

Higher costs for complex cancer surgery may be an indicator for worse, rather than better, quality of care, according to new research by the Baker Institute and the University of Texas MDAnderson Cancer Center. The study suggests that lower patient costs achieved by high-volume surgeons can be explained by the lower occurrence of “processes of care”— many of which are taken to avoid or treat complications that can occur during surgery, such as placing arterial lines or providing epidural anesthesia.

Health care providers add multiple processes to the care of complex cancer patients, believing they prevent and/or ameliorate complications. However, the relationship between these processes, complication remediation, and expenditures is unknown.

Errors in surgical care for cancer patients may seem infrequent, but the costs associated with them are extremely high.